Skip to main content
Premium Trial:

Request an Annual Quote

Amarantus Licenses Power3 Test for Parkinson's Disease

NEW YORK (GenomeWeb News) – Amarantus BioSciences today said that it has licensed exclusive, worldwide rights from Power3 Medical Products to a test for Parkinson's disease diagnosis.

Power3's NuroPro Blood Test has been developed for the early detection of neurodegenerative diseases. It monitors the concentration of 57 protein markers in blood serum that have been linked to neurodegeneration, and according to the firms, can accurately detect and distinguish Alzheimer's disease, ALS, and Parkinson's disease. The test is being developed to help assist physicians in diagnosing disease and monitoring progression, the firms added.

Sunnyvale, Calif.-based Amarantus, which is developing a disease-modifying protein therapeutic for treatment of Parkinson's disease, paid a $25,000 exclusivity fee in common stock in November and will issue to Power3 $475,000 worth of common stock. In addition, it signed an option to purchase all of the Parkinson's Disease IP owned by Power3 for $500,000 worth of common stock and maintains a right of first refusal to acquire the balance of the NuroPro platform for Alzheimer's disease, ALS, and all other neurodegenerative diseases.

The terms of the license is one year and is renewable upon mutual written agreement between the firms.

"Now that we will be able to tailor our therapeutic development pathway towards a companion diagnostic product that we control, Amarantus is positioned to build a strategic advantage over competitors as the execution of our clinical and regulatory strategy continues to advance [Mesencephalic-Astrocyte-derived Neurotrophic Factor] as a disease-modifying treatment for Parkinson's disease," Gerald Commissioning, president and CEO of Amarantus BioSciences, said in a statement.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.